#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13520	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2140	628.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1435	1435	C	779	C	717	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13520	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2140	628.0	0	HET	.	.	.	C207T	.	207	207	C	458	458	C	721	C,T	332,324	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24362	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	680.4	0	.	n	.	0	T695C	SNP	695	695	T	1072	1072	C	722	C	685	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24362	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	680.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	2015	2015	G	799	G,A	740,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24362	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	680.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2348	2348	C	745	C	684	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24362	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	680.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2422	2422	A	731	A	688	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24362	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3567	680.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2974	2974	C	703	C,A	668,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1814	folP	855	855	100.0	folP.l15.c30.ctg.1	1474	122.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1006	1008	AGC	202;196;199	A;G;C	187;183;185	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5080	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3436	147.3	1	SNP	p	S91F	1	.	.	271	273	TTC	653	655	TTC	186;189;190	T;T;C	171;173;171	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5080	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3436	147.3	1	SNP	p	D95G	1	.	.	283	285	GGC	665	667	GGC	201;196;193	G;G;C	180;177;177	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5080	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3436	147.3	1	SNP	p	G95N	0	.	.	283	285	GGC	665	667	GGC	201;196;193	G;G;C	180;177;177	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1450	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1284	112.5	1	SNP	p	G45D	0	.	.	133	135	GGC	474	476	GGC	179;177;177	G;G;C,A	166;164;163,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	670	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1136	58.5	0	.	n	.	0	A197.	DEL	197	197	A	551	551	A	161	A	152	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4522	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2977	151.2	1	SNP	p	D86N	0	.	.	256	258	GAC	543	545	GAC	171;172;171	G;A;C	162;161;161	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4522	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2977	151.2	1	SNP	p	R87I	0	.	.	259	261	CGT	546	548	CGT	170;171;170	C;G;T,C	160;162;159,2	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4522	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2977	151.2	1	SNP	p	S87R	1	.	.	259	261	CGT	546	548	CGT	170;171;170	C;G;T,C	160;162;159,2	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4522	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2977	151.2	1	SNP	p	R87W	0	.	.	259	261	CGT	546	548	CGT	170;171;170	C;G;T,C	160;162;159,2	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4522	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2977	151.2	1	SNP	p	S88P	0	.	.	262	264	TCC	549	551	TCC	172;176;176	T;C;C	162;166;166	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3950	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2614	150.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1446	1448	GGC	193;191;184	G;G,A;C	176;174,1;163	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3696	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2381	154.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1233	1235	GCC	194;195;194	G;C;C	181;181;181	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3696	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2381	154.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1236	1238	ATG	193;194;195	A;T;G	181;182;182	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3696	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2381	154.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1248	1250	ACC	198;198;198	A;C;C	189;190;190	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3696	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2381	154.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1248	1250	ACC	198;198;198	A;C;C	189;190;190	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3696	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2381	154.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1749	1751	ACC	196;196;198	A;C;C	185;185;186	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3696	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2381	154.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1803	1805	GCG	183;183;185	G;C;G	167;170;171	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3696	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2381	154.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1803	1805	GCG	183;183;185	G;C;G	167;170;171	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3696	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2381	154.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1926	1928	GGT	146;143;145	G;G;T	139;136;133	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3696	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2381	154.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1935	1937	AGC	131;130;126	A;G;C	120;120;116	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3696	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2381	154.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1953	1955	CCG	115;119;120	C,G;C;G	89,3;92;93	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5104	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3184	159.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1664	1666	CCG	221;220;218	C;C,T;G	196;199,2;198	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2094	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1756	118.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	496	496	C	122	C	118	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	A251V	NONSYN	751	753	GCG	81	83	GTA	29;29;29	G;T,C;A,G	28;27,1;27,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	S271T	NONSYN	811	813	TCG	141	143	ACT	50;48;47	A;C;T	44;43;42	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	147	149	GAT	37;36;35	G;A;T	33;33;32	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	D276N	NONSYN	826	828	GAT	156	158	AAC	35;35;35	A;A;C	32;32;32	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	N277H	NONSYN	829	831	AAC	159	161	CAC	35;35;35	C;A;C	32;32;32	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	R307E	NONSYN	919	921	AGA	249	251	GAA	13;13;13	G;A;A	13;13;13	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	T311A	NONSYN	931	933	ACA	261	263	GCA	12;12;12	G;C;A	12;12;11	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	E312D	NONSYN	934	936	GAA	264	266	GAC	11;11;10	G;A;C	11;11;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	F314I	NONSYN	940	942	TTC	270	272	ATC	8;8;8	A;T;C	8;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	A316S	NONSYN	946	948	GCG	276	278	TCG	7;7;7	T;C;G	7;7;7	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	V318A	NONSYN	952	954	GTC	282	284	GCC	7;7;6	G;C;C	7;7;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	G319S	NONSYN	955	957	GGC	285	287	AGC	7;7;7	A;G;C	5;6;6	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	G320A	NONSYN	958	960	GGT	288	290	GCC	7;7;7	G;C;C	7;6;6	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	242	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	390	21.8	0	.	p	.	0	G322V	NONSYN	964	966	GGT	294	296	GTT	8;8;7	G;T;T	7;8;6	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2556	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1579	160.8	0	.	p	.	0	I45V	NONSYN	133	135	ATT	369	371	GTT	209;208;207	G,A;T;T	194,1;193;190	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2556	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1579	160.8	1	SNP	p	G120K	1	.	.	358	360	AAG	594	596	AAG	191;191;194	A;A;G	172;174;175	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2556	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1579	160.8	1	SNP	p	N121D	0	.	.	361	363	AAC	597	599	AAC	196;195;198	A;A;C	180;181;178	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2556	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1579	160.8	1	SNP	p	A121N	1	.	.	361	363	AAC	597	599	AAC	196;195;198	A;A;C	180;181;178	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9326	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4765	194.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1074	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1138	94.0	1	SNP	p	V57M	1	.	.	169	171	ATG	532	534	ATG	220;220;219	A,G;T;G	203,1;205;200	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
